Pierre-Marie Roy Selected Research

Histamine Antagonists (Antihistamines)

1/2019

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Marie Roy Research Topics

Disease

31	Pulmonary Embolism 06/2023 - 09/2002
10	Venous Thromboembolism 11/2023 - 03/2004
10	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 03/2004
6	Hemorrhage 07/2022 - 08/2019
4	Neoplasms (Cancer) 01/2023 - 01/2006
3	Thrombosis (Thrombus) 11/2023 - 04/2015
3	Myocardial Infarction 12/2022 - 10/2018
3	ST Elevation Myocardial Infarction 12/2022 - 01/2021
3	Chest Pain (Chest Pains) 12/2022 - 10/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2018
3	Thromboembolism 01/2022 - 04/2005
2	Critical Illness (Critically Ill) 06/2023 - 04/2005
2	COVID-19 06/2023 - 08/2021
2	Acute Coronary Syndrome 01/2021 - 10/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Obesity 06/2023
1	Infections 06/2023
1	Hypothyroidism 11/2022
1	Postthrombotic Syndrome 07/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Hematoma 01/2021
1	Urticaria (Hives) 01/2019
1	Hemoptysis 01/2019
1	Disseminated Intravascular Coagulation 12/2018
1	Hypotension (Low Blood Pressure) 08/2012
1	Shock 08/2012
1	Tinnitus 02/2007
1	Headache (Headaches) 02/2007
1	Nausea 02/2007
1	Photophobia (Light Sensitivity) 02/2007
1	Lung Diseases (Lung Disease) 02/2006
1	Heart Failure 02/2006
1	Fever (Fevers) 01/2006
1	Esophagitis 04/2005
1	Gastroesophageal Reflux (GERD) 04/2005

Drug/Important Bio-Agent (IBA)

23	fibrin fragment D (D-dimer)IBA 11/2023 - 03/2004
12	AnticoagulantsIBA 01/2022 - 01/2006
5	TroponinIBA 12/2022 - 08/2012
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2012
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2023 - 12/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2023 - 01/2022
2	Dalteparin (Dalteparin Sodium)FDA Link 07/2022 - 01/2022
2	Enoxaparin (Lovenox)FDA LinkGeneric 07/2022 - 07/2011
2	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 07/2021
2	edoxabanIBA 07/2022 - 07/2021
2	omega-Chloroacetophenone (Mace)IBA 08/2021 - 10/2018
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 08/2019
2	Natriuretic PeptidesIBA 06/2013 - 08/2012
1	cupric sulfide (CuS)IBA 01/2023
1	factor AIBA 01/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022
1	Tinzaparin (Innohep)FDA Link 07/2022
1	Nadroparin (Nadroparin Calcium)IBA 07/2022
1	Fondaparinux (Arixtra)FDA Link 07/2022
1	RivaroxabanIBA 01/2022
1	Oxygen (Dioxygen)IBA 08/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2021
1	Vitamin K FDA Link 12/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	Dabigatran FDA Link 01/2020
1	idarucizumabIBA 01/2020
1	GlucocorticoidsIBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	levocetirizine FDA LinkGeneric 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 06/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2013
1	LatexIBA 07/2005
1	ImmunosorbentsIBA 03/2004
1	EnzymesIBA 03/2004
1	ElementsIBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2006
2	Ambulatory Care (Outpatient Care) 07/2011 - 11/2008
1	Hospice Care (Care, Bereavement) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Operative Surgical Procedures 01/2020
1	Vena Cava Filters (Inferior Vena Cava Filter) 04/2015
1	Contraindications 08/2012
1	Thrombolytic Therapy 08/2012
1	Punctures 02/2007
1	Bed Rest (Bedrest) 02/2007
1	Gastrostomy 04/2005